Unknown

Dataset Information

0

Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction.


ABSTRACT: SOCS-1 (suppressor of cytokine signaling-1) is a representative of a family of negative regulators of cytokine signaling (SOCS-1 to SOCS-7 and CIS) characterized by a highly conserved C-terminal SOCS box preceded by an SH2 domain. This study comprehensively examined the ability of several SOCS family members to negatively regulate the gp130 signaling pathway. SOCS-1 and SOCS-3 inhibited both interleukin-6 (IL-6)- and leukemia inhibitory factor (LIF)-induced macrophage differentiation of murine monocytic leukemic M1 cells and LIF induction of a Stat3-responsive reporter construct in 293T fibroblasts. Deletion of amino acids 51-78 in the N-terminal region of SOCS-1 prevented inhibition of LIF signaling. The SOCS-1 and SOCS-3 N-terminal regions were functionally interchangeable, but this did not extend to other SOCS family members. Mutation of SH2 domains abrogated the ability of both SOCS-1 and SOCS-3 to inhibit LIF signal transduction. Unlike SOCS-1, SOCS-3 was unable to inhibit JAK kinase activity in vitro, suggesting that SOCS-1 and SOCS-3 act on the JAK-STAT pathway in different ways. Thus, although inhibition of signaling by SOCS-1 and SOCS-3 requires both the SH2 and N-terminal domains, their mechanisms of action appear to be biochemically different.

SUBMITTER: Nicholson SE 

PROVIDER: S-EPMC1171132 | BioStudies | 1999-01-01T00:00:00Z

SECONDARY ACCESSION(S): AC005131

REPOSITORIES: biostudies

Similar Datasets

1999-01-01 | S-EPMC26738 | BioStudies
2002-01-01 | S-EPMC133908 | BioStudies
2007-01-01 | S-EPMC2225448 | BioStudies
1998-01-01 | S-EPMC18144 | BioStudies
2012-01-01 | S-EPMC3394197 | BioStudies
2006-01-01 | S-EPMC1472497 | BioStudies
1999-01-01 | S-EPMC22025 | BioStudies
2013-01-01 | S-EPMC3749136 | BioStudies
2020-01-01 | S-EPMC7269991 | BioStudies
2019-01-01 | S-EPMC6468919 | BioStudies